SPANISH
CONTACT US
CONTACT US
MPF Investment Map
Facebook Twitter Instagram

Pfizer

Topic: Domestic Health
Action:

Challenged; SEC decided in company’s favor and resolution will be excluded from the 2017 proxy.

Resolution Text:

Resolution requesting the Board of Directors issue a report by November 1, 2017, at reasonable expense and excluding proprietary information, listing the rates of price increases year-to-year of our company’s top ten selling branded prescription drugs between 2010 and 2016, including the rationale and criteria used for these price increases, and an assessment of the legislative, regulatory, reputational and financial risks they represent for our company.

RESOURCES

Human Trafficking Map

Interfaith Center on Corporate Responsibility

UN Principles for Responsible Investing

Ceres

Climate Action 100+

Investor Environmental Health Network

Catholic Impact Investing Collaborative

Opportunity Finance Network

Inclusiv

Mission Investors Exchange

MERCY INVESTING NEWS

Healthy Planet

Healthy Persons and Communities

Human Rights and Equity

Shareholder Advocacy

Environmental Solutions Fund 

Mercy Partnership Fund

Inclusive Opportunities Fund

We and selected third parties use cookies or similar technologies for technical purposes and, with your consent, for other purposes. You can consent to the use of such technologies by using the “Accept” button, by closing this notice, by scrolling this page, by interacting with any link or button outside of this notice or by continuing to browse otherwise.

ACCEPT